Amicus Therapeutics, Inc

FOLDNASDAQUSD
14.49 USD
0.03 (0.21%)AT CLOSE (11:59 AM EDT)
14.50
0.01 (0.03%)
POST MARKET (AS OF 04:49 PM EDT)
Post Market
AS OF 04:49 PM EDT
14.50
0.01 (0.03%)
🔴Market: CLOSED
Open?$14.49
High?$14.50
Low?$14.49
Prev. Close?$14.46
Volume?5.3M
Avg. Volume?3.3M
VWAP?$14.49
Rel. Volume?1.62x
Bid / Ask
Bid?$0.00 × 0
Ask?$0.00 × 0
Spread?$0.00
Midpoint?$0.00
Valuation & Ratios
Market Cap?4.5B
Shares Out?314.0M
Float?291.0M
Float %?92.7%
P/E Ratio?N/A
P/B Ratio?16.59
EPS?-$0.09
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.84Strong
Quick Ratio?1.88Adequate
Cash Ratio?0.90Adequate
Debt/Equity?1.43Moderate
ValuationRICHLY VALUED
Score
33/100
P/E?
N/A
P/B?
16.59HIGH
P/S?
7.17HIGH
P/FCF?
152.4PRICEY
EV/EBITDA?
112.7HIGH
EV/Sales?
7.46HIGH
Returns & Efficiency
ROE?
-9.9%WEAK
ROA?
-2.9%WEAK
Cash Flow & Enterprise
FCF?$29.8M
Enterprise Value?$4.7B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Employees
511
Market Cap
4.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2007-05-31
Address
47 HULFISH STREET
PRINCETON, NJ 08542
Phone: (609) 662-2000